Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)

The summary for the Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional): The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of Digital Therapeutics (DTx) to treat Substance Use Disorders (SUDs). Advances in technology offer unprecedented opportunities to develop clinical-grade mobile, web, or other software-based platforms designed to deliver treatments that are safe and effective for SUD. FDA authorization of DTx can play an important role in increasing the availability of treatments to patients with SUD, although there are other pathways for dissemination of this class of intervention. The primary objective of this FOA is to move DTx to their next step in the development process, with the ultimate goal of generating new, FDA authorized, disseminated treatments for SUDs. Applications may focus on the pre-clinical and/or clinical development and testing of new DTx or existing DTx developed for other indications.

Federal Grant Title:	Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-21-183
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.279
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 6th, 2023
Original Application Deadline:	December 6th, 2023
Posted Date:	March 23rd, 2021
Creation Date:	March 23rd, 2021
Archive Date:	January 5th, 2024
Total Program Funding:
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 21st, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-21-183.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...; • Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Tr...; • Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship an...; • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional); • Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Accelerating Research and Development of Next Generation Vaccines against Malaria - a Mode...; • Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (Sen...; • Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed); • Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory ...; • Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARR...